melphalan
Selected indexed studies
- Melphalan Flufenamide (Melflufen): First Approval. (Drugs, 2021) [PMID:33961277]
- Melphalan: Recent insights on synthetic, analytical and medicinal aspects. (Eur J Med Chem, 2022) [PMID:35665692]
- Melphalan hydrochloride for the treatment of multiple myeloma. (Expert Opin Pharmacother, 2017) [PMID:28658983]
_Worker-drafted node — pending editorial review._
Connections
melphalan is a side effect of
Sources
- Melphalan Flufenamide (Melflufen): First Approval. (2021) pubmed
- Melphalan: Recent insights on synthetic, analytical and medicinal aspects. (2022) pubmed
- Melphalan hydrochloride for the treatment of multiple myeloma. (2017) pubmed
- Melphalan and its role in the management of patients with multiple myeloma. (2007) pubmed
- Melphalan. (2011) pubmed
- Melphalan. (1990) pubmed
- The systemic administration of intravenous melphalan. (1988) pubmed
- Melphalan. (2004) pubmed
- Targeting MCM6 Enhances Melphalan Chemosensitivity in Retinoblastoma by Modulating DNA Damage Response. (2025) pubmed
- In brief: Melphalan (Hepzato) for uveal melanoma. (2023) pubmed